Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N07XX02	RILUTEK	B	Riluzole - 50mg	50mg	Tablet, film coated	15,886,212 L.L
C01EB18	RANEXA	B	Ranolazine - 500mg	500mg	Tablet, prolonged release	3,985,837 L.L
D06BX01	ROZEX	B	Metronidazole - 0.75g/100g	0.75%	Gel	584,571 L.L
C01EB18	RANEXA	B	Ranolazine - 750mg	750mg	Tablet, prolonged release	3,985,837 L.L
J06BB01	RHOPHYLAC 300	BioHuman	Human anti-D (rh) immunoglobulin - 300mcg/2ml	300mcg/2ml	Injectable solution	5,939,784 L.L
J06BB01	RHESONATIV	BioHuman	Human anti-D (rh) immunoglobulin - 625IU/ml	625IU/ml	Injectable solution	12,281,758 L.L
J06BB05	RABISHIELD-100 (RABIES HUMAN MONOCLONAL ANTIBODY rDNA)	BioHuman	Rabies, Human IgG1 Monoclonal Antibody - 100IU/2.5ml	100IU/2.5ml		8,455,824 L.L
B02BD02	RECOFACT VIII	BioTech	Moroctocog alfa - 500IU	500IU	Injectable powder for solution+diluent	12,049,005 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	76,080,435 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	149,006,276 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	298,171,406 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	47,533,131 L.L
L03AB07	RECIGEN 44	BioTech	Interferon beta-1a - 44mcg/0.5ml	44mcg/0.5ml	Injectable solution	L.L
L03AB07	REBIF	BioTech	Interferon beta-1a - 44mcg/0.5ml	12MIU	Injectable solution	82,479,505 L.L
L03AB07	RECIGEN 44	BioTech	Interferon beta-1a - 44mcg/0.5ml	44mcg/0.5ml	Injectable solution	15,147,973 L.L
J07BG01	RABIVAX-S (RABIES VACCINE INACTIVATED)	BioTech	Freeze dried inactivated purified rabies antigen (Pitman Moore PM3218 as virus strain) -		Injectable freeze dried material	1,552,138 L.L
J07BH01	ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL FREEZE-DRIED)	BioTech	Rotavirus bovine-human , live attenuated -		Suspension	2,822,069 L.L
J07BH01	ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID)	BioTech	Rotavirus bovine-human , live attenuated -		Liquid	2,822,069 L.L
L01FA01	RITUXIREL	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrated solution	L.L
A10AD06	RYZODEG	BioTech	Insulin degludec - 70%, Insulin aspart - 30%	100IU/ml	Injectable solution	7,058,661 L.L
L01FA01	RITUXIREL	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrated solution	L.L
L03AB07	REBIF	BioTech	Interferon beta-1a - 44mcg/0.5ml	12MIU	Injectable solution	L.L
C10AX13	REPATHA	BioTech	Evolocumab - 140mg/1ml		Injectable solution	44,151,793 L.L
B03XA06	REBLOZYL	BioTech	Luspatarcept - 25mg	25mg	Injectable powder for solution	125,960,784 L.L
L01FA01	RITUXIREL	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrated solution	11,708,063 L.L
B03XA06	REBLOZYL	BioTech	Luspatercept - 75mg	75mg	Injectable powder for solution	377,881,318 L.L
L01FA01	RIXATHON	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	28,438,096 L.L
L01FA01	RUXIENCE	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	13,157,756 L.L
L01FA01	RITUXIREL	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrated solution	45,258,360 L.L
L01FA01	RIXATHON	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	66,951,899 L.L

...